| Application no. and date | 11721616.8 (espacenet) (Federated) (European Patent Register), 20110511 | | Patent/reg. no. and date | DK/EP 2568988, 20160713 | | Publication date | 20130320 | | Priority no. and date | US 333495 P, 20100511 | | EP pub. no. and date |
EP 2568988 20130320 | | Effective date | | | Applicant/owner | Janssen Pharmaceutica, N.V., Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | P59104dk01 | | Inventor | WANG, Wenhua, 329 Crittenden Drive
New Hope
PA 18940, US,
OUTWIN, Todd, 209 Hunter Way
Chalfont
PA 18914, US,
JOSEPH, Thomas C., 1936 Fernbrook Avenue
Oakford
PA 19503, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/381 (2006.01) , A61K 31/7004 (2006.01) , A61K 31/7042 (2006.01) , A61K 47/26 (2006.01) , A61K 47/38 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61P 3/10 (2006.01) | | Title | FARMACEUTISKE FORMULERINGER OMFATTENDE 1-(BETA-D-GLUCOPYRANOSYL)-2-THIENYLMETHYLBENZEN-DERIVATER SOM INHIBITORER AF SGLT | | Int. application no. | US2011036038 | | Int. publication no. | WO2011143296 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
